16 results
Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity

Mechanism of Action,
Table of Weight-Loss ... the long-term treatment ... /Bupropion ER ... #Pharmacology #Table ... #Comparison
Topical drug formulations, comparison and considerations

#pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
formulations, comparison ... #pharmacology #table ... #medications #comparison ... #drugs #treatment ... pharmacotherapy #dermatology
Bullous pemphigoid and pemphigus vulgaris

Comparison Table via Physical Examination, Nikolsky Sign and Differential Diagnoses

#Diagnosis #Dermatology #Bullous
pemphigus vulgaris Comparison ... Table via Physical ... Nikolsky Sign and Differential ... #Diagnosis #Dermatology ... #Comparison #Table
Thrombotic Microangiopathy - TTP VS HUS

Big picture points : Often hard to differentiate the two entities,
Often hard to differentiate ... and first-line treatment ... thrombocytopenia #Comparison ... #Diagnosis #Table ... #Hematology
Approach to the Rash in a an oncology patient - MINT-C Mnemonic
M - Malignancy: Leukemia cutis,
the Rash in a an oncology ... Gangrenosum, NEH T - Treatment ... #skin #Rash #oncology ... #differential # ... MINTC #Mnemonic #dermatology
Human Granulocytic Anaplasmosis vs Ehrlichiosis vs Babesiosis
Nonspecific febrile illness with severe headache and myalgia.
Diagnosis: NAAT, Blood
Ioxedes Tick - Treatment ... Ioxedes Tick - Treatment ... tick #tickborne #differential ... #diagnosis #comparison ... #table
Severe Drug Rashes - Comparison - DRESS | SJS/TEN | AGEP | Erythroderma

DRESS 
 - Onset:
Drug Rashes - Comparison ... #Drug #Rashes #Comparison ... #TABLE #DRESS # ... #Erythroderma #Dermatology ... #Emergency #Differential
Hodgkin's Lymphoma vs Non-Hodgkin's Lymphoma - Comparison

Hodgkin's Lymphoma:
 • Epidemiology: young adults 20-30, older 50-70
 •
Non-Hodgkin's Lymphoma - Comparison ... #NonHodgkins #comparison ... #oncology #diagnosis ... #differential # ... hematology
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
: 33% • Treatment ... : No • Treatment ... Transfusion #Reactions #hematology ... #diagnosis #comparison ... #table
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
interactions) Cancer-treatment ... #Chemotherapy #Oncology ... #Hematology #Interactions ... #Table #Pharmacology